Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | FGFR3 N540K |
| Therapy | Fexagratinib |
| Indication/Tumor Type | Advanced Solid Tumor |
| Response Type | resistant |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| FGFR3 N540K | Advanced Solid Tumor | resistant | Fexagratinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells over expressing FGFR3 N540K were reistant to growth inhibition by Fexagratinib (AZD4547) in culture (PMID: 26992226). | 26992226 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (26992226) | Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use. | Full reference... |